Platelet survival and morphology in homocystinuria due to cystathionine synthase deficiency
- PMID: 980060
- DOI: 10.1056/NEJM197612022952303
Platelet survival and morphology in homocystinuria due to cystathionine synthase deficiency
Abstract
In homocystinuria due to cystathionine synthase deficiency thromboembolism is a major cause of mortality and morbidity. Recent studies by others identified an abnormally shortened platelet survival and increased platelet vacuolization in patients with homocystinuria. When we studied six additional patients, however, we found the platelet survival to be within normal limits for each. The mean survival (+/-1 S.D.) was 9.75+/-0.94 days (normal, 9.27+/-1.06). In addition, platelets from five patients with homocystinuria and three obligate heterozygotes could not be distinguished from those of seven normal control subjects by electron microscopy. Specifically, no increased vacuolization was observed. Genetic heterogeneity, technical differences of differences in plasma homocystine concentrations could account for these descrepant results. The mechanism of thrombosis in homocystinuria remains an open question.
Similar articles
-
Platelet and monocyte variables in homocystinuria due to cystathionine-beta-synthase deficiency.Haematologica. 1997 Mar-Apr;82(2):189-90. Haematologica. 1997. PMID: 9175326
-
Homocystinuria due to a cystathionine beta-synthase deficiency: clinical manifestations and therapy.Johns Hopkins Med J. 1980 Mar;146(3):110-7. Johns Hopkins Med J. 1980. PMID: 7359798 No abstract available.
-
Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency.Thromb Haemost. 1999 Apr;81(4):502-5. Thromb Haemost. 1999. PMID: 10235428
-
Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.Semin Thromb Hemost. 2000;26(3):335-40. doi: 10.1055/s-2000-8100. Semin Thromb Hemost. 2000. PMID: 11011851 Review.
-
Homocystinuria: pathogenetic mechanisms.Am J Med Sci. 1977 Mar-Apr;273(2):120-32. Am J Med Sci. 1977. PMID: 324277 Review.
Cited by
-
Increased prostacyclin biosynthesis in a patient with homocystinuria.Eur J Pediatr. 1990 Jun;149(9):666-7. doi: 10.1007/BF02034761. Eur J Pediatr. 1990. PMID: 2115445 No abstract available.
-
Angiographic findings in homocystinuria.Cardiovasc Intervent Radiol. 1983;6(3):125-8. doi: 10.1007/BF02552761. Cardiovasc Intervent Radiol. 1983. PMID: 6627257
-
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism.J Clin Invest. 1993 Sep;92(3):1400-6. doi: 10.1172/JCI116715. J Clin Invest. 1993. PMID: 8376592 Free PMC article.
-
Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor.J Clin Invest. 1993 Jun;91(6):2873-9. doi: 10.1172/JCI116532. J Clin Invest. 1993. PMID: 8390492 Free PMC article.
-
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.J Clin Invest. 1986 Jun;77(6):1909-16. doi: 10.1172/JCI112519. J Clin Invest. 1986. PMID: 3519683 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources